In this report, CBRE profiles a selection of nine city-based ecosystems across Europe, and Gothenburg is one of them. These have been chosen not based on size or ranking, but because they have unique capabilities and future potential, with key assets showcased such as universities, research institutes, incubators, and a diverse mix of occupiers.

We look at the locational structure of each ecosystem, and the ability of each to attract funding, with a focus on VC. We include a case study of a prominent institution or development in each as well as aspects of the real estate landscape. Metrics explored include stock levels, typical rents and key transactions – as well as the potential represented by future development pipelines. 

Life sciences is one of Gothenburg’s fastest growing sectors, and the region is home to one of Sweden’s and Europe’s largest university hospital. One of AstraZeneca’s five global strategic R&D centres, the largest hospital in the Nordics and over 700 companies, employing 10,000 people in total.

The life sciences cluster in Mölndal, known as GoCo Health Innovation City, is expanding rapidly, with approximately €400 million being invested in the project. Located adjacent to AstraZeneca’s R&D centre is under development and will grow by 200,000 sq m to accommodate 350 companies and 7,000 people.

Read more in the report, you find it here.

For more information and questions please contact your advisor at CBRE, or 
Michaela Capkova or Anders Hansén.